Dyax Corp. to Participate in Upcoming 2013 Healthcare Conferences

Published: Feb 20, 2013

Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in two upcoming conferences, providing a corporate update regarding the Company’s key value drivers – the KALBITOR®(ecallantide) business and the angioedema portfolio, as well as the Licensing and Funded Research Program (LFRP).

Back to news